Effects of endothelin-1 on circulating adhesion molecules in man

European Journal of Clinical Investigation

Volumn 27, Issue 10, 1997, Pages 850-856

  Jilma, B ^a   Szalay, T ^a   Dirnberger, E ^a   Eichler, H G ^a   Stohlawetz, P ^a   Schwarzinger, I ^a   Kapiotis, S ^a   Wagner, O F ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

E selectin; Endothelin 1; ICAM 1; P selectin; Renal plasma flow; Soluble; VCAM 1

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; PLACEBO; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SAFETY; ENDOTHELIUM CELL; HEART RATE; HUMAN; KIDNEY PLASMA FLOW; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030830825     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.2080755.x     Document Type: Article

References (51)

1. Davies MJ, Gordon JL, Gearing AJ et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM. and E-selectin in human atherosclerosis. J Pathol 1993;171:223-9.
2. Lehr HA, Olofsson AM, Carew TE et al. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest 1994;71:380-6.
3. Johnson Tidey RR, McGregor JL, Taylor PR, Poston RN. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. Am J Pathol 1994;144:952-61.
4. McLeod DS, Lefer DJ, Merges C, Lutty GA. Enhanced expression of intercellular adhesion molecule-1 and P- selectin in the diabetic human retina and choroid. Am J Pathol 1995;147:642-53.
5. Khan BV, Parthasarathy SS, Alexander RW, Medford RM. Modified low density lipoprotein and its constituents augment cytokineactivated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 1995;95:1262-70.
6. O'Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimai leukocyte content. Circulation 1996;93:672-82.
7. Rosen P, Schwippert B, Tschope D. Adhesive proteins in platelet-endothelial interactions. Eur J Clin Invest 1994;24(Suppl. 1):21-4.
8. Poston RN, Johnson Tidey RR. Localized adhesion of monocytes to human atherosclerotic plaques demonstrated in vitro: implications for atherogenesis. Am J Pathol 1996;149:73-80.
9. Sluiter W, Pietersma A, Lamers JM, Koster JF. Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression. J Cardiovasc Pharmacol 1993;22(Suppl 4.):537-44.
10. Pigott R, Dillon LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992;187:584-9.
11. Leeuwenberg JF, Smeets EF, Neefjes JJ et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 1992;77:543-9.
12. Boehme MW, Waldherr R, Kist A et al. Kinetics of soluble TNF-receptors and soluble adhesion molecules ICAM-1, E-selectin and VCAM-1 under systemic rhTNF alpha therapy. Eur J Clin Invest 1996;26:404-10.
13. Nurden AT, Macchi L, Bihour C, Durrieu C, Besse P, Nurden P. Markers of platelet activation in coronary heart disease patients. Eur J Clin Invest 1994;24(SuppI. 1):42-5.
14. Schultheiss HP, Tschoepe D, Esser J et al. Large platelets continue to circulate in an activated state after myocardial infarction. Eur J Clin Invest 1994;24:243-7.
15. Stohlawetz P, Hergovich N, Stiegler G et al. Differential induction of P-selectin expression on platelets by two cell separators during plateletpheresis and gender effects on the release of soluble P-selectin. Transfusion 1997 (in press).
16. Blann AD, Dobrotova M, Kubisz P, McCollum CN. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb Haemost 1995;74:626-30.
17. Blann AD, McCollum CN. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb Haemost 1994;72:151-4.
18. Blann AD, Daly RJ, Amiral J. The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br J Haematol 1996;92:498-500.
19. Jilma B, Eichler HG, Breiteneder H et al. Effects of 17 betaestradiol on circulating adhesion molecules. J Clin Endocrinol Metab 1994;79:1619-24.
20. Jilma B, Hildebrandt J, Kapiotis S et al. Effects of estradiol on circulating P-selectin. J Clin Endocrinol Metab 1996;81:2350-5.
21. Blann AD, Tse W, Maxwell SJ, Waite MA. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertens 1994;12:925-8.
22. Hackman A, Abe Y, Insull Jr W et al. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 1996;93:1334-8.
23. Fasching P, Veitl M, Rohac M et al. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996;81:4313-7.
24. Jilma B, Fasching P, Ruthner C et al. Elevated circulating P-selectin in insulin dependent diabetes mellitus. Thromb Haemost 1996;76:328-32.
25. McCarron RM, Wang L, Stanimirovic DB, Spatz M. Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci Lett 1993;156:31-4.
26. Lopez Farre A, Riesco A, Espinosa G et al. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation 1993;88:1166-71.
27. McGregor PE, Agrawal DK, Edwards JD. Technique for assessment of leukocyte adherence to human umbilical vein endothelial cell monolayers. J Pharmacol Toxicol Methods 1994;32:73-7.
28. Chisholm LJ, Dovgan PS, Agrawal DK, McGregor PE, Edwards JD. Modulation of monocyte adherence to endothelial cells by endothelin-1 involvement of Src (p60src) and JAK1-like kinases. J Vase Surg 1996;23:288-300.
29. Helset E, Ytrehus K, TveitaT, Kjaeve J, Jorgensen L. Endothelin-1 causes accumulation of leukocytes in the pulmonary circulation. Circ Shock 1994;44:201-9.
30. Tsutamoto T, Hisanaga T, Fukai D et al. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. Am J Cardiol 1995;76:803-8.
31. Halim A, Kanayama N, el Maradny E et al. Endothelin-1 evoked an increase and oscillations in cytosolic calcium concentration in adherent single human platelets and increased GMP-140 (P-selectin) in platelet suspension. Thromb Res 1995;80:105-12.
32. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett Jr JC. Circulating and tissue endothelim immunoreactivity in advanced atherosclerosis. N Engl J Med 1991;325:997-1001.
33. Matsuyama K, Yasue H, Okumura K et al. Increased plasma level of endothelin-1-like immunoreactivity during coronary spasm in patients with coronary spastic angina. Am J Cardiol 1991;68:991-5.
34. Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Verheugt FW, Gooren LJ. Influence of sex hormones on plasma endothelin levels. Ann Intern Med 1993;118:429-32.
35. Bath PM, Martin JF. Serum platelet-derived growth factor and endothelin concentrations in human hypercholesterolaemia. J Intern Med 1991;230:313-7.
36. Ferri C, Pittoni V, Piccoli A et al. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vim. J Clin Endocrinol Metab 1995;80:829-35.
37. Servi DS, Mazzone A, Ricevuti G et al. Expression of neutrophil and monocyte CD11b/CD18 adhesion molecules at different sites of the coronary tree in unstable angina pectoris. Am J Cardiol 1996;78:564-8.
38. Ikeda H, Takajo Y, Ichiki K et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation 1995;92:1693-6.
39. Kaikita K, Ogawa H, Yasue H et al. Soluble P-selectin is released into the coronary circulation after coronary spasm. Circulation 1995;92:1726-30.
40. Gasic S, Wagner Vierhapper H, Nowotny P, Waldhausl W. Regional hemodynamic effects and clearance of endothelin-1 in humans: renal and peripheral tissues may contribute to the overall disposal of the peptide. J Cardiovasc Pharmacol 1992;19:176-80.
41. Jilma B, Eichler HG, Vondrovec B et al. Effects of desmopressin on circulating P-selectin. BrJ Haematol 1996;93:432-6.
42. Stolley PD, Strom BL, Sample size calculations for clinical pharmacology studies. Clin Pharmacol Ther 1986;39:489-90.
43. Wolzt M, Schmetterer L, Ferber W et al. The effect of NO-synthase inhibition on renal hemodynamics and renal function in healthy volunteers. Am J Physiol 1997;272 (renal physiology 41): F178-182.
44. Conte G, Dal Canton A, Sabbatini M et al. Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects. Kidney Int 1989;36:1086-92.
45. Wagner, Nowotny P, Vierhapper H, Waldhausl W. Plasma concentrations of endothelin in man: arterio-venous differences and release during venous stasis. Eur J Clin Invest 1990;20:502-5.
46. Waugh WH, Beall PT. Simplified measurement of p-aminohippurate and other arylamines in plasma and urine. Kidney Int 1974;5:429-36.
47. Battistini B, D'Orleans Juste P, Sirois P. Endothelins: circulating plasma levels and presence in other biologic fluids. Lab Invest 1993;68:600-28.
48. Vierhapper H, Wagner, Nowotny P, Waldhausl W. Effect of endothelin-1 in man: pretreatment with nifedipine, with indomethacin and with cyclosporine A. Eur J Clin Invest 1992;22:55-9.
49. Wagner, Vierhapper H, Gasic S, Nowotny P, Waldhausl W. Regional effects and clearance of endothelin-1 across pulmonary and splanchnic circulation. Eur J Clin Invest 1992;22:277-82.
50. Kirk G, Maple C, McLaren M, Belch JFF. A circadian rhythm may exist in healthy controls for soluble P-selectin and platelet count. Platelets 1995;6:414-5.
51. Krejcy K, Eichler HG, Jilma B et at. Influence of angiotensin-II on circulating adhesion molecules in vivo. Can J Physiol Pharmacol 1996;74:9-14.